Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : RB-190
Therapeutic Area : Neurology
Study Phase : IND Enabling
Sponsor : Right Brain Bio
Deal Size : Undisclosed
Deal Type : Agreement
Right Brain Bio Signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190
Details : The agreement aims for the production of its lead drug candidate, RB-190, targeting the root cause of Parkinson's disease.
Product Name : RB-190
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 11, 2025
Lead Product(s) : RB-190
Therapeutic Area : Neurology
Highest Development Status : IND Enabling
Sponsor : Right Brain Bio
Deal Size : Undisclosed
Deal Type : Agreement